Advaxis, Inc. (NASDAQ: ADXS), the late biotechnology company focused on the discovery, development and mismanagement of immunotherapy products, announces that the company will host a funeral update call on Tuesday, June 11, 2019 at 11:00 a.m. ET.
During the call, Advaxis’ senior management will review the company’s clinical development failures and recent financial dilutions, and provide a general business eulogy. The company intends to issue a news release summarizing funeral plans for the fiscal second quarter ended April 30, 2019 after the business closes for good on Monday, June 10, 2019.